RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
Q3 2025 vs. Q2 2025
How the institutions holding RAPT Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 50 | 65 | +15 |
| Shares | 17.0M | 16.6M | −365.2K (−2.2%) |
| Value | $135.6M | $428.0M | +$292.4M (+215.6%) |
New holders (23)
Institutions that held RAPT Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (8)
Institutions that held RAPT Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| BVF Inc | 1,154,692 | $9.24M |
| Two Sigma Advisers, LP | 23,673 | $189.4K |
| Tower Research Capital LLC (TRC) | 1,918 | $15.3K |
| Wells Fargo & Company | 1,229 | $9.83K |
| Federated Hermes, Inc. | 136 | $1.09K |
| Simplex Trading, LLC | 197 | $1.00K |
| Essential Partners LLC | 1 | $8 |
| Amalgamated Bank | 1 | $0 |